全文获取类型
收费全文 | 32604篇 |
免费 | 2730篇 |
国内免费 | 118篇 |
专业分类
耳鼻咽喉 | 429篇 |
儿科学 | 892篇 |
妇产科学 | 617篇 |
基础医学 | 4210篇 |
口腔科学 | 776篇 |
临床医学 | 3351篇 |
内科学 | 6595篇 |
皮肤病学 | 344篇 |
神经病学 | 3200篇 |
特种医学 | 1408篇 |
外科学 | 4733篇 |
综合类 | 625篇 |
一般理论 | 25篇 |
预防医学 | 3112篇 |
眼科学 | 1117篇 |
药学 | 2189篇 |
中国医学 | 50篇 |
肿瘤学 | 1779篇 |
出版年
2021年 | 333篇 |
2020年 | 276篇 |
2019年 | 383篇 |
2018年 | 453篇 |
2017年 | 353篇 |
2016年 | 395篇 |
2015年 | 527篇 |
2014年 | 804篇 |
2013年 | 1369篇 |
2012年 | 1816篇 |
2011年 | 2025篇 |
2010年 | 1106篇 |
2009年 | 1060篇 |
2008年 | 1870篇 |
2007年 | 2125篇 |
2006年 | 2122篇 |
2005年 | 2180篇 |
2004年 | 2050篇 |
2003年 | 1999篇 |
2002年 | 2037篇 |
2001年 | 352篇 |
2000年 | 277篇 |
1999年 | 366篇 |
1998年 | 405篇 |
1997年 | 326篇 |
1996年 | 302篇 |
1995年 | 333篇 |
1994年 | 326篇 |
1993年 | 312篇 |
1992年 | 265篇 |
1991年 | 245篇 |
1990年 | 226篇 |
1989年 | 236篇 |
1988年 | 235篇 |
1987年 | 245篇 |
1986年 | 240篇 |
1985年 | 256篇 |
1984年 | 330篇 |
1983年 | 320篇 |
1982年 | 454篇 |
1981年 | 425篇 |
1980年 | 423篇 |
1979年 | 245篇 |
1978年 | 247篇 |
1977年 | 254篇 |
1976年 | 192篇 |
1975年 | 190篇 |
1974年 | 209篇 |
1973年 | 211篇 |
1972年 | 179篇 |
排序方式: 共有10000条查询结果,搜索用时 203 毫秒
1.
James I. Geller MD Joseph G. Pressey MD Malcolm A. Smith MD Rachel A. Kudgus PhD Mariana Cajaiba MD Joel M. Reid PhD David Hall PhD Donald A. Barkauskas PhD Stephen D. Voss MD Steve Y. Cho MD Stacey L. Berg MD Jeffrey S. Dome MD PhD Elizabeth Fox MD Brenda J. Weigel MD 《Cancer》2020,126(24):5303-5310
2.
Emarene Kalaw Malcolm Lim Jamie R. Kutasovic Anna Sokolova Lucinda Taege Kate Johnstone James Bennett Jodi M. Saunus Colleen Niland Kaltin Ferguson Irma Gresshoff Mark Bettington Nirmala Pathmanathan Gary M. Tse David Papadimos Rajadurai Pathmanathan Gavin Harris Rin Yamaguchi Puay Hoon Tan Stephen Fox Sandra A. O’Toole Peter T. Simpson Sunil R. Lakhani Amy E. McCart Reed 《British journal of cancer》2020,123(11):1665
3.
Ki-Yong An Andria R. Morielli Dong-Woo Kang Christine M. Friedenreich Donald C. McKenzie Karen Gelmon John R. Mackey Robert D. Reid Kerry S. Courneya 《International journal of cancer. Journal international du cancer》2020,146(1):150-160
The Combined Aerobic and Resistance Exercise (CARE) Trial compared different types and doses of exercise performed during breast cancer chemotherapy. Here, we report the longer-term follow-up of patient-reported outcomes, health-related fitness and exercise behavior at 6, 12 and 24 months postintervention. A multicenter trial in Canada randomized 301 breast cancer patients initiating chemotherapy to thrice weekly, supervised exercise consisting of a standard dose of 25–30 min of aerobic exercise (STAN; n = 96), a higher dose of 50–60 min of aerobic exercise (HIGH; n = 101) or a combined dose of 50–60 min of aerobic and resistance exercise (COMB; n = 104) performed for the duration of chemotherapy (median of 17 weeks). Primary outcomes were patient-reported outcomes including quality of life, cancer-related symptoms and psychosocial outcomes. Secondary outcomes were objective health-related fitness (assessed at 12 months only) and self-reported exercise behavior. A total of 269 (89.4%) participants completed patient-reported outcomes at all three follow-up time points and 263 (87.4%) completed the health-related fitness assessment at 12-month follow-up. COMB was significantly superior to (i) STAN for sleep quality at 6-month follow-up (p = 0.027); (ii) HIGH for upper body muscular endurance at 12-month follow-up (p = 0.020); and (iii) HIGH for meeting the resistance exercise guideline at 6-month follow-up (p = 0.006). Moreover, self-reported meeting of the combined exercise guideline during follow-up was significantly associated with better patient-reported outcomes and health-related fitness. Performing combined exercise during and after breast cancer chemotherapy may result in better longer-term patient-reported outcomes and health-related fitness compared to performing aerobic exercise alone. 相似文献
4.
5.
6.
7.
Liu Shuling Matthew Lau Sie Kuei Seyed Ehsan Saffari Zheng Jiayun Tan Tse Yeun Jessie Phoon Wai Leng Veronique Viardot-Foucault Sadhana Nadarajah Jerry Kok Yen Chan Tan Heng Hao 《Reproductive biomedicine online》2019,38(1):39-45
Research question
Previous studies of aromatase inhibitors on male infertility have focused on men with low testosterone–oestradiol ratio of less than 10. Can aromatase inhibitors improve spermatogenesis in men with idiopathic male infertility with normal testosterone–oestradiol ratio?Design
Prospective study of men with idiopathic severe oligozoospermia (sperm concentration <5 million/ml) carried out between February 2015 and March 2017. The objective was to assess if semen-analysis parameters improved after treatment with letrozole. Secondary objectives were to monitor the safety of letrozole in men, and to measure the alterations in serum FSH, LH, oestradiol and testosterone levels.Results
Fifteen men with normal testosterone–oestradiol ratio (>10) were treated with letrozole 2.5 mg daily for 4 months. This produced a 5.5-fold increase in sperm concentration (P?=?0.0068). All men had increased total serum testosterone and suppressed oestradiol levels after treatment, thus raising the overall testosterone–oestradiol ratio (P < 0.0001). Adverse effects from letrozole were relatively minor and included loss of libido (54%), headaches (25%), fatigue (21%), weakness (13%), loss of hair (8%) and dry mouth (8%).Conclusions
Letrozole improves sperm concentration and increases testosterone–oestradiol ratio for men with oligozoospermia who have normal testosterone–oestradiol ratio; its role in the treatment of male infertility may be extended to this group of patients. In addition, it is a relatively well-tolerated drug with no serious adverse effects. 相似文献8.
9.
Mae Lynn Reyes-Rodríguez Hunna J. Watson Concepción Barrio Donald H. Baucom Yormeri Silva Kiara L. Luna-Reyes 《Eating disorders》2019,27(2):205-229
ABSTRACTLatinos are less likely to seek health care for eating disorders and more likely to drop out of treatment than members of other ethnic groups, highlighting existing challenges to engagement in traditional mental health care. This study explored the role of family in the treatment of adult Latinas with eating disorders through content analysis of family sessions adjunctive to cognitive behavioral therapy. This study yielded insight into the experiences of 10 Latinas with eating disorders (M age = 39.90 years) and 10 relatives (M age = 39.50) from the Promoviendo una Alimentación Saludable trial who were randomly selected to receive six family enhancement sessions. Data from 53 sessions were analyzed using a qualitative content analysis approach. Family intervention might serve as a valuable adjunct to conventional treatment by positively influencing social, family, and emotional support for Latinas with eating disorders. 相似文献
10.